Dr. Edward Machtinger
1. Recent trauma is associated with antiretroviral failure and HIV transmission risk behavior among HIV-positive women and female-identified transgenders. Read Paper
2. Psychological trauma and PTSD in HIV-positive women: a meta-analysis. Read Paper
3. Atraumatic splenic rupture: an unusual manifestation of acute HIV infection. Read Paper
4. A visual medication schedule to improve anticoagulation control: a randomized, controlled trial. Read Paper
5. Seven steps to better adherence: a practical approach to promoting adherence to antiretroviral therapy.
Read Paper
6. The importance of establishing regimen concordance in preventing medication errors in anticoagulant care.
Read Paper
7. Etiology of pruritic papular eruption with HIV infection in Uganda. Read Paper
Jennifer Cocohoba, PharmD
1. Improved antiretroviral refill adherence in HIV-focused community pharmacies. Read Paper
2. Impact of HIV-specialized pharmacies on adherence and persistence with antiretroviral therapy. Read Paper
3. Pharmacist counseling in a cohort of women with HIV and women at risk for HIV. Read Paper
4. Making sense of side effects. Read Paper
5. The impact of HIV clinical pharmacists on HIV treatment outcomes: a systematic review. Read Paper
6. Health care provider satisfaction with telephone consultations provided by pharmacists and physicians at the National HIV/AIDS Clinicians’ Consultation Center. Read Paper
7. A comparison of tenofovir-associated renal function changes in HIV-infected African Americans vs Caucasians. Read Paper
8. Influence of gender on receipt of guideline-based antiretroviral therapy in the era of HAART. Read Paper
9. The impact of the AIDS Drug Assistance Program (ADAP) on use of highly active antiretroviral and antihypertensive therapy among HIV-infected women. Read Paper
10. Hormonal contraception for HIV positive women. Read Paper
11. The SWITCHMRK studies: substitution of lopinavir/ritonavir with raltegravir in HIV-positive individuals. Read Paper
12. Raltegravir: the first HIV integrase inhibitor. Read Paper
13. HIV postexposure prophylaxis availability in U.S. rural hospitals. Read Paper
14. Effects of HIV antiretrovirals on the pharmacokinetics of hormonal contraceptives. Read Paper
15. Consistency of initial antiretroviral therapy with HIV treatment guidelines in a US cohort of HIV-infected women. Read Paper
16. Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients. Read Paper
17. Refusals by pharmacists to dispense emerging contraception: a critique. Read Paper
18. Tipranavir: a protease inhibitor for HIV salvage therapy. Read Paper
19. Potential adverse effects and inferior efficacy in ARV treatment. Read Paper
20. Valganciclovir: an advance in cytomegalovirus therapeutics. Read Paper
Dr. Deborah Cohan
1. Neonatal Mortality in HIV-Exposed Infants Born to Women Receiving Combination Antiretroviral Therapy in Rural Uganda. Read Paper
2. CDC should reverse its recommendation against semen washing-intrauterine insemination for HIV-serodifferent couples. Read Paper
3. The Cost-Effectiveness of Repeat HIV Testing During Pregnancy in a Resource-Limited Setting. Read Paper
4. HIV and reproduction: fertility, contraception, and preconception issues and interventions. Read Paper
5. Antiretrovirals and safer conception for HIV-serodiscordant couples. Read Paper
6. Trends in contraceptive use among women with human immunodeficiency virus. Read Paper
7. Evaluating safer conception options for HIV-serodiscordant couples (HIV-infected female/HIV-uninfected male): a closer look at vaginal insemination. Read Paper
8. Preexposure prophylaxis for the prevention of HIV transmission to women. Read Paper
9. Maternal nutritional status predicts adverse birth outcomes among HIV-infected rural Ugandan women receiving combination antiretroviral therapy. Read Paper
10. Contraceptive use and barriers to access among newly arrested women. Read Paper